Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
15hon MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
A record-breaking 4,432 scientific abstracts accepted at the American Heart Association’s meeting here adorned posters, ...
Jarome and his team found that aging disrupts K63 polyubiquitination in two distinct areas of the brain. In the hippocampus, ...
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback